Parkman Healthcare Partners’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
270,131
+35,347
| +15% | +$351K | 0.31% | 74 |
|
|
2025
Q1 | $3.05M | Buy |
234,784
+13,804
| +6% | +$179K | 0.36% | 66 |
|
|
2024
Q4 | $2.82M | Buy |
220,980
+1,529
| +0.7% | +$19.5K | 0.38% | 63 |
|
|
2024
Q3 | $2.44M | Buy |
219,451
+2,629
| +1% | +$29.3K | 0.31% | 69 |
|
|
2024
Q2 | $2.43M | Sell |
216,822
-49,688
| -19% | -$558K | 0.33% | 71 |
|
|
2024
Q1 | $3.31M | Buy |
266,510
+12,563
| +5% | +$156K | 0.41% | 69 |
|
|
2023
Q4 | $3.55M | Buy |
+253,947
| New | +$3.55M | 0.5% | 60 |
|
|
2020
Q4 | – | Sell |
-200,000
| Closed | -$864K | – | 87 |
|
|
2020
Q3 | $864K | Buy |
+200,000
| New | +$864K | 0.23% | 74 |
|